Health Care - Spark Newswire

1 minute read

FDA Expands EUA for Lower Dose Subcutaneous Version of Regeneron’s COVID-19 Antibody Cocktail

Today, 3:22 PM

The FDA has authorized a new, lower-dose version of Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) COVID-19 monoclonal antibody cocktail for those with COVID-19 who…

REGN

1 minute read

Surface Oncology’s SRF388 Shows Promising Anticancer Activity in Pretreated Patients

By Vandana Singh

Today, 3:22 PM

Surface Oncology (NASDAQ:SURF) has announced new data from the ongoing Phase 1 studies of SRF388 and SRF617. SRF388 data will be…

SURF

1 minute read

4D pharma To Stop Testing Asthma Med in COVID-19 Patients

By Vandana Singh

Today, 3:22 PM

4D pharma plc (NASDAQ: LBPS) has completed its target enrollment of 30 patients for Part A of its Phase 1/2 trial of MRx-4DP0004 in patients with partly controlled asthma.

LBPS

1 minute read

Sanofi Inks Partnership for Late-Stage Trial of Amcenestrant as Add-On Breast Cancer Therapy

By Vandana Singh

Today, 3:22 PM

Sanofi SA (NASDAQ:SNY) has secured partners for a Phase 3 trial to study amcenestrant versus the hormone therapy tamoxifen in breast…

SNY

1 minute read

Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer

By Vandana Singh

Today, 3:22 PM

Surface Oncology (NASDAQ:SURF) has entered into a clinical trial collaboration with Roche Holdings AG (OTC:RHHBY) to evaluate former’s SRF388, anti-IL-27 antibody, in combination…

RHHBF

1 minute read

Coherus, Junshi Toripalimab-Chemo Combo Beat Chemo Alone in Late-Stage Nose & Throat Cancer Trial

By Vandana Singh

Today, 3:22 PM

Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ:CHRS) have announced positive results from the pivotal Phase 3 JUPITER-02 trial evaluating toripalimab…

CHRS

1 minute read

Nanobiotix’s Nanoparticle Technology Shows Tumor-Killing Effect in Early-Stage Head & Neck Cancer

By Vandana Singh

Today, 3:22 PM

Nanobiotix (NASDAQ:NBTX), ahead of the 2021 Annual Meeting of the American Society for Clinical Oncology meeting, has said that…

NBTX

2 minute read

Bristol Myers Touts Opdivo Win in Esophageal Cancer, But Yervoy-Opdivo Combo Comes with Caution

By Vandana Singh

Today, 3:22 PM

Bristol Myers Squibb & Co (NYSE: BMY) announced results from the Phase 3 CheckMate-648 trial, which had two Opdivo-based treatment combinations…

BMY

1 minute read

AstraZeneca, Merck Lynparza Earns Win in Early Breast Cancer, Showing Potential in Post-Surgery Setting

By Vandana Singh

Today, 3:22 PM

AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc (NYSE:MRK) have announced the first presentation of data from the Phase 3 OlympiA trial evaluating…

AZN

1 minute read

Merck’s Keytruda Shows Clinical Benefit in Post-Surgery Kidney Cancer Setting

By Vandana Singh

Today, 3:22 PM

Merck & Co (NYSE:MRK) announced first-time results from the pivotal Phase 3 KEYNOTE-564 trial evaluating Keytruda for the potential adjuvant treatment…

MRK